drugset / Trial / NCT01163097

Study to Characterize the Effect of Heparin on Palifermin Activity

NCT01163097

Phase 1 Completed 44 enrolled Swedish Orphan Biovitrum
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of a continuous intravenous infusion of unfractionated heparin on the multiple-dose pharmacodynamics of palifermin in healthy adult subjects.

Timeline

Start
2010-07
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified Intravenous
Subject Palifermin Protein / enzyme biologic 40 ug/kg Intravenous

Indications